These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38372774)

  • 1. Leveraging Cross-Linking Mass Spectrometry for Modeling Antibody-Antigen Complexes.
    Di Ianni A; Di Ianni A; Cowan K; Barbero LM; Sirtori FR
    J Proteome Res; 2024 Mar; 23(3):1049-1061. PubMed ID: 38372774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of HER2 binding domain in antigen-antibody complexes based on chemical crosslinking mass spectrometry.
    Wang L; Xie L; Zhang Z
    J Proteomics; 2023 Aug; 286():104954. PubMed ID: 37390893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leveraging crosslinking mass spectrometry in structural and cell biology.
    Graziadei A; Rappsilber J
    Structure; 2022 Jan; 30(1):37-54. PubMed ID: 34895473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope and Paratope Mapping of PD-1/Nivolumab by Mass Spectrometry-Based Hydrogen-Deuterium Exchange, Cross-linking, and Molecular Docking.
    Zhang MM; Huang RY; Beno BR; Deyanova EG; Li J; Chen G; Gross ML
    Anal Chem; 2020 Jul; 92(13):9086-9094. PubMed ID: 32441507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-linking and mass spectrometry as a tool for studying the structural biology of ribonucleoproteins.
    Sarnowski CP; Bikaki M; Leitner A
    Structure; 2022 Apr; 30(4):441-461. PubMed ID: 35366400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol for structural modeling of antibody to human leukocyte antigen interaction using discovery and targeted cross-linking mass spectrometry.
    Ser Z; Gascoigne NRJ; MacAry PA; Sobota RM
    STAR Protoc; 2024 Mar; 5(1):102927. PubMed ID: 38431839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xlink Analyzer: software for analysis and visualization of cross-linking data in the context of three-dimensional structures.
    Kosinski J; von Appen A; Ori A; Karius K; Müller CW; Beck M
    J Struct Biol; 2015 Mar; 189(3):177-83. PubMed ID: 25661704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Cross-Linking Mass Spectrometry on Single-Step Affinity Purified Molecular Complexes in the Yeast Saccharomyces cerevisiae.
    Trahan C; Oeffinger M
    Methods Mol Biol; 2022; 2456():185-210. PubMed ID: 35612743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distance restraints from crosslinking mass spectrometry: mining a molecular dynamics simulation database to evaluate lysine-lysine distances.
    Merkley ED; Rysavy S; Kahraman A; Hafen RP; Daggett V; Adkins JN
    Protein Sci; 2014 Jun; 23(6):747-59. PubMed ID: 24639379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do Not Waste Time─Ensure Success in Your Cross-Linking Mass Spectrometry Experiments before You Begin.
    Nouchikian L; Fernandez-Martinez D; Renard PY; Sabot C; Duménil G; Rey M; Chamot-Rooke J
    Anal Chem; 2024 Feb; 96(6):2506-2513. PubMed ID: 38294351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of homodimer interfaces with cross-linking mass spectrometry and isotopically labeled proteins.
    Lima DB; Melchior JT; Morris J; Barbosa VC; Chamot-Rooke J; Fioramonte M; Souza TACB; Fischer JSG; Gozzo FC; Carvalho PC; Davidson WS
    Nat Protoc; 2018 Mar; 13(3):431-458. PubMed ID: 29388937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining Electron Microscopy (EM) and Cross-Linking Mass Spectrometry (XL-MS) for Structural Characterization of Protein Complexes.
    Quintana-Gallardo L; Maestro-López M; Martín-Benito J; Marcilla M; Rutz D; Buchner J; Valpuesta JM; Cuéllar J
    Methods Mol Biol; 2022; 2420():217-232. PubMed ID: 34905177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational Structure Prediction for Antibody-Antigen Complexes From Hydrogen-Deuterium Exchange Mass Spectrometry: Challenges and Outlook.
    Tran MH; Schoeder CT; Schey KL; Meiler J
    Front Immunol; 2022; 13():859964. PubMed ID: 35720345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling Protein Complexes Using Restraints from Crosslinking Mass Spectrometry.
    Bullock JMA; Sen N; Thalassinos K; Topf M
    Structure; 2018 Jul; 26(7):1015-1024.e2. PubMed ID: 29804821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural probing of a protein phosphatase 2A network by chemical cross-linking and mass spectrometry.
    Herzog F; Kahraman A; Boehringer D; Mak R; Bracher A; Walzthoeni T; Leitner A; Beck M; Hartl FU; Ban N; Malmström L; Aebersold R
    Science; 2012 Sep; 337(6100):1348-52. PubMed ID: 22984071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Evolving Contribution of Mass Spectrometry to Integrative Structural Biology.
    Faini M; Stengel F; Aebersold R
    J Am Soc Mass Spectrom; 2016 Jun; 27(6):966-74. PubMed ID: 27056566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-state modeling of antibody-antigen complexes with SAXS profiles and deep-learning models.
    Cohen T; Halfon M; Carter L; Sharkey B; Jain T; Sivasubramanian A; Schneidman-Duhovny D
    Methods Enzymol; 2023; 678():237-262. PubMed ID: 36641210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-linking/mass spectrometry at the crossroads.
    Piersimoni L; Sinz A
    Anal Bioanal Chem; 2020 Sep; 412(24):5981-5987. PubMed ID: 32472143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling Antibody-Antigen Complexes by Information-Driven Docking.
    Ambrosetti F; Jiménez-García B; Roel-Touris J; Bonvin AMJJ
    Structure; 2020 Jan; 28(1):119-129.e2. PubMed ID: 31727476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysine-specific chemical cross-linking of protein complexes and identification of cross-linking sites using LC-MS/MS and the xQuest/xProphet software pipeline.
    Leitner A; Walzthoeni T; Aebersold R
    Nat Protoc; 2014 Jan; 9(1):120-37. PubMed ID: 24356771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.